Please Wait...

Bioclinica Appoints New Chief Financial Officer, William Hogan

November 29, 2017

DOYLESTOWN, Pa., – Bioclinica®, a world-leading provider of specialty clinical trial services, has appointed William Hogan as the company's Executive Vice President and Chief Financial Officer. Former CFO David Peters is stepping down to pursue other career opportunities.

William Hogan joins Bioclinica from Multi Packaging Solutions (“MPS”), a multinational, $2 billion manufacturer of specialty packaging for the pharmaceutical and consumer products industries. He was CFO for 12 years and served on the leadership team that managed MPS’s global expansion through several transactions including the sale of the business. His experience meeting the needs of the world's top pharmaceutical companies will provide great insight into serving Bioclinica customers.

Prior to MPS, Hogan held CFO roles in multinational product and services-based businesses, both public reporting companies and private equity owned organizations, as well as 12 years with Deloitte. He is a certified public accountant and has extensive experience in the strategic, financial and operational management of multinational organizations. He brings a strong track record of increasing shareholder value and meeting the challenges created by evolving companies and rapidly changing economic and competitive environments.

David Herron, who will assume the role of Chief Executive of Bioclinica in January, said, “I would like to welcome Bill Hogan to Bioclinica, and, on behalf of the Board, we look forward to working with him to grow the business.  Bill brings with him significant CFO experience from a variety of different businesses and his experience with over 19 acquisitions transactions will be an asset to Bioclinica.”

Hogan said, “Bioclinica is a world-leading provider of specialty clinical trial services and has ambitious plans for the future. I am delighted to have joined Bioclinica and am excited to be working alongside the Bioclinica management team to support the growth strategy. Bioclinica has a great team in place with an outstanding reputation and I look forward to our future success.”

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company's thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Hello from Clinical Operations in Oncology Trials East Coast where Bioclinica is exhibiting & presenting a case stu… https://t.co/oTKJAVddH4
bioclinica (3 days ago)
Challenge overcome! Course-correct a clinical trial & collect 400 time points from 40 sites across the US & EU -- a… https://t.co/n3TLrjW3xi
bioclinica (3 days ago)
Ck out this go-to-guide on #Alzheimer's research! Get insights on optimizing medical imaging endpoints, patient re… https://t.co/UKuVoBvBBJ
bioclinica (5 days ago)
Challenge overcome! Our VP Global Project Mgmt Craig Picinich presents a case study 7/11 at Clinical Operations in… https://t.co/g69Olt8Upn
bioclinica (6 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still others in the industry rem… https://t.co/SSf9wGPtAz
bioclinica (6 days ago)
RT @ArenaIntPharma: Meet with key representatives from companies such as @bioclinica @IQVIA_global @precisionmedcin @myClin @MassBio and m…
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen